Luye Pharma Group Ltd. (OTCMKTS:LYPHF – Get Free Report) was the recipient of a large growth in short interest in May. As of May 15th, there was short interest totaling 286,500 shares, a growth of 139.7% from the April 30th total of 119,500 shares. Based on an average daily trading volume, of 18 shares, the short-interest ratio is presently 15,916.7 days.
Luye Pharma Group Price Performance
Shares of LYPHF stock remained flat at $0.33 during midday trading on Tuesday. The firm’s fifty day moving average is $0.35 and its 200 day moving average is $0.37. Luye Pharma Group has a 12-month low of $0.30 and a 12-month high of $0.33.
About Luye Pharma Group
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
Featured Articles
- Five stocks we like better than Luye Pharma Group
- Alphabet’s $80 Billion Offering: Worrisome Dilution or AI Confidence?
- MGM Buyout: The House Doesn’t Always Win
- Survey Reveals the Historic Main Streets People Most Want Revived [2026]
- 5 Reasons to Pony Up for Pony AI Stock—and 1 Reason to Wait
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
